EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CD169 + Macrophage‐Targeted Immunomodulator to Restore Phagocytic Function and Enhance Antigen Presentation for Lymphatic Metastasis Eradication

Xiayun Chen, Lichong Lu, Yibin Liu, Ziqi Liang, Jianqiao Li, Zhouchuan Shao, Youzhi Tang, Jianhua Zou, Shiying Li, Xiaoyuan Chen iD

Advanced Science · 2026

DOI: 10.1002/advs.202514386 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Xiayun Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, the Sc…. Hauptthemen laut MEDLINE: Antigen Presentation, Macrophages, Sialic Acid Binding Ig-like Lectin 1, Lymphatic Metastasis. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Open Project of State Key Laboratory of Respiratory Disease.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lymphatic metastasis is a major cause of tumor treatment failure, with the immunosuppressive status of lymphatic macrophages significantly impairing antitumor immunity. In this study, it is found that CD169 + macrophages in lymphatic metastasis exhibit impaired phagocytic activity and diminished antigen‐presenting capacity, which correlates with suppressed antitumor immune responses. Based on these discoveries, a CD169 + macrophage‐targeted immunomodulator (designated as G‐LNP@S‐D) is fabricated to restore phagocytic function and enhance antigen presentation for lymphatic metastasis eradication. G‐LNP@S‐D consists of GM1‐functionalized liposomes co‐encapsulating the SHP2 inhibitor SHP099 and the STING agonist DMXAA, enabling sequential lymph node‐ and CD169 + macrophage‐specific drug delivery. Mechanistically, G‐LNP@S‐D not only restores the phagocytic capacity of CD169 + macrophages to eliminate tumor cells but also activates the STING pathway to enhance antigen presentation and subsequent T cell priming. Immunological profiling confirms that G‐LNP@S‐D treatment promotes the infiltration of CD4 + and CD8 + T cells in both TDLNs and primary tumors. Importantly, G‐LNP@S‐D exerts systemic immunomodulatory effects for directly eradicating lymphatic metastases. This study elucidates a sophisticated lymph node immune‐modulation strategy and provides a promising therapeutic approach to treat lymphatic metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigen PresentationMacrophagesSialic Acid Binding Ig-like Lectin 1Lymphatic MetastasisPhagocytosisImmunologic FactorsImmunomodulating AgentsAnimalsMiceMice, Inbred C57BLFemaleCell Line, TumorHumans

Stichwörter der Autor:innen

drug deliverylymphatic metastasesmacrophage polarizationtumor immunotherapy

Substanzen

Sialic Acid Binding Ig-like Lectin 1Immunologic FactorsImmunomodulating Agents

Autor:innen und Institutionen

  • The Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, the School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzh…
  • Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics, Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural University, Guangzhou, 510642, P. R. China.
  • Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119074, Singapore.
  • Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore.
  • Theranostics Center of Excellence (TCE), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 138667, Singapore.
  • Department of Chemical and Biomolecular Engineering, College of Design and Engineering, National University of Singapore, Singapore, 117575, Singapore.

ORCID-Profile: Xiaoyuan Chen

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • Open Project of State Key Laboratory of Respiratory Disease
  • National University of Singapore
  • National Medical Research Council
  • National Research Foundation
  • National Key Research and Development Program of China

Zitieren

APA

Chen, X., Lu, L., Liu, Y., Liang, Z., Li, J., Shao, Z., Tang, Y., Zou, J., Li, S., & Chen, X. (2026). CD169 + Macrophage‐Targeted Immunomodulator to Restore Phagocytic Function and Enhance Antigen Presentation for Lymphatic Metastasis Eradication. Advanced Science. https://doi.org/10.1002/advs.202514386

Vancouver

Chen X, Lu L, Liu Y, Liang Z, Li J, Shao Z, et al. CD169 + Macrophage‐Targeted Immunomodulator to Restore Phagocytic Function and Enhance Antigen Presentation for Lymphatic Metastasis Eradication. Advanced Science. 2026. doi:10.1002/advs.202514386

BibTeX
@article{Chen2026,
  author = {Chen, Xiayun and Lu, Lichong and Liu, Yibin and Liang, Ziqi and Li, Jianqiao and Shao, Zhouchuan and Tang, Youzhi and Zou, Jianhua and Li, Shiying and Chen, Xiaoyuan},
  title = {CD169 + Macrophage‐Targeted Immunomodulator to Restore Phagocytic Function and Enhance Antigen Presentation for Lymphatic Metastasis Eradication},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202514386}
}
Kostenlos starten →